Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Healthtrust
AstraZeneca
Medtronic
Queensland Health
McKinsey
Harvard Business School
Federal Trade Commission
Moodys
Boehringer Ingelheim

Generated: January 22, 2018

DrugPatentWatch Database Preview

KYTRIL Drug Profile

« Back to Dashboard

Which patents cover Kytril, and when can generic versions of Kytril launch?

Kytril is a drug marketed by Roche and is included in three NDAs. There is one patent protecting this drug and three Paragraph IV challenges.

This drug has twenty-six patent family members in nineteen countries.

The generic ingredient in KYTRIL is granisetron hydrochloride. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the granisetron hydrochloride profile page.
Summary for KYTRIL
Drug patent expirations by year for KYTRIL

US Patents and Regulatory Information for KYTRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-003 Sep 17, 2004 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-002 Jun 15, 1998 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-002 Mar 11, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-004 Mar 11, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-001 Dec 29, 1993 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-001 Mar 16, 1995 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride SOLUTION;ORAL 021238-001 Jun 27, 2001 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for KYTRIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-002 Jun 15, 1998 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-003 Sep 17, 2004 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-002 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-001 Dec 29, 1993 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride TABLET;ORAL 020305-001 Mar 16, 1995 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-002 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-004 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-004 Mar 11, 1994 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride INJECTABLE;INJECTION 020239-001 Dec 29, 1993 ➤ Subscribe ➤ Subscribe
Roche KYTRIL granisetron hydrochloride SOLUTION;ORAL 021238-001 Jun 27, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for KYTRIL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Injection 0.1 mg/mL, 1 mL single dose vial ➤ Subscribe 3/8/2007
➤ Subscribe Injection 1 mg/mL, 4 mL multi-dose vials ➤ Subscribe 7/19/2004
➤ Subscribe Injection 1 mg/mL, 1 mL vials ➤ Subscribe 6/1/2004

International Patents for KYTRIL

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Daiichi Sankyo
Colorcon
Baxter
Medtronic
Healthtrust
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot